brain/CNS |
brain |
CD133, HER2, PSMA |
|
glioma |
B7-H3, CD147, EGFR, EGFRvIII, EphA2, GD2, HER2, IL13Rα2, MUC1, CD133 |
|
glioblastoma |
B7-H3, ligands of chlorotoxin, EGFRvIII, HER2, IL13Rα2, NKG2D-Ligands, PD-L1 |
|
primitive neuroectodermal tumor |
B7-H3 |
|
choroid plexus carcinoma |
B7-H3 |
|
pineoblastoma |
B7-H3 |
|
CNS tumor |
B7-H3, EGFR806, HER2 |
|
ependymoma |
B7-H3 |
|
medulloblastoma |
B7-H3, NKG2D-Ligands |
several organs |
rhabdoid tumor |
B7-H3, EGFR, GPC3 |
|
Rhabdomyosarcoma |
B7-H3, EGFR, GPC3 |
|
desmoplastic small round cell tumor |
B7-H3, EGFR |
|
sarcoma |
GD2, HER2, NKG2D-Ligands, CD133, MUC1, CD117 |
|
adenocarcinoma |
CEA |
|
solid tumors |
B7-H3, CEA, claudin 18.2, EGFR, EGFR family member, GD2, GPC3, HER2, Lewis Y, mesothelin, MUC1, MUC16ecto, TnMuc1, Nectin4, ROR2 |
pancreas |
pancreatic |
CD70, CD133, CEA, claudin 18.2, EGFR, EpCAM, HER2, mesothelin, MUC1, Nectin4, NKG2D-Ligands, PSCA, ROR2, EGFRvIII |
|
pancreatic ductal adenocarcinoma |
claudin 18.2, mesothelin, TnMuc1 |
liver |
liver |
CD133, CEA, EGFR, EpCAM, GPC3, MG7, NKG2D-Ligands |
|
HCC (hepatocellular carcinoma) |
AFP/HLA-A2, CD147, GPC3, MUC1, NKG2D-Ligands, c-MET, PD-L1 |
|
hepatoblastoma |
B7-H3, EGFR |
|
hepatoma |
several |
|
gall bladder carcinoma |
EGFR |
|
cholangiocarcinoma |
EGFR, HER2, MUC1 |
lung |
lung |
CEA, EGFR, HER2, mesothelin, Lewis Y, PSCA, MUC1, PD-L1, CD80/86, MAGE-A1, MAGE-A4, GD2 |
|
small cell lung cancer |
DLL3 |
|
mesothelioma |
FAP, mesothelin |
|
lung squamous cell carcinoma |
GPC3 |
|
NSCLC |
EGFR, mesothelin, MUC1, TnMuc1, Nectin4, PD-L1, ROR1, CD80/86 |
uterus/cervix |
ovarian |
CD70, CD133, CEA, EGFR, FBP, HER2, mesothelin, TnMuc1, Nectin4, NKG2D-Ligands |
|
cervical |
mesothelin, GD2, PSMA, MUC1, mesothelin |
|
fallopian tube |
mesothelin, TnMuc1 |
breast |
breast |
CD44v6, CD70, CD133, CEA, c-MET, EpCAM, HER2, mesothelin, Muc1 (cleaved from), Nectin4, GD2 |
|
TNBC |
c-MET, mesothelin, MUC1, TnMuc1, NKG2D-Ligands, ROR1 |
colon |
colorectal |
CD133, CEA, EGFR, HER2, MUC1, NKG2D-Ligands |
|
colon |
EpCAM, HER2, NKG2D-Ligands |
kidney |
renal |
CD70, EGFR, VEGFR2, ROR2, AXL |
|
neuroblastoma |
B7-H3, CD171, EGFR, GD2, PSMA |
|
wilms tumor |
B7-H3, EGFR, GPC3 |
stomach |
gastric |
CD44v6, CEA, claudin 18.2, EGFR, EpCAM, HER2, MUC1, NKG2D-Ligands, PSCA, ROR2 |
prostate |
prostate |
CD44v6, EpCAM, NKG2D-Ligands, PSCA, PSMA |
head/neck |
esophageal |
EpCAM, HER2, MUC1 |
|
nasopharyngeal |
EpCAM, LMP1, NKG2D-Ligands |
|
SCCHN |
ErbB dimers, HER2 |
|
salivary gland |
HER2 |
|
thyroid cancer |
ICAM1 |
skin |
melanoma |
B7-H3, CD20, CD70, c-MET, GD2, gp100/HLA-A2, IL13Rα2, VEGFR2 |
bladder |
bladder |
HER2, Nectin4, NKG2D-Ligands, ROR2, PSMA, FBP |
soft tissue |
synovial sarcoma |
B7-H3, EGFR |
|
clear cell sarcoma |
B7-H3, EGFR |
|
soft tissue sarcoma |
B7-H3, EGFR, GPC3, ROR2 |
bone |
osteosarcoma |
B7-H3, EGFR, GD2 |
|
ewing sarcoma |
B7-H3, EGFR |
abdomen |
peritoneal |
CEA, EpCAM, mesothelin |
eye |
retinoblastoma |
B7-H3, EGFR |
|
uveal melanoma |
GD2 |
ovary/testis |
germ cell tumor |
B7-H3, EGFR, GPC3 |
peripheral nerves |
malignant peripheral nerve sheath tumor |
B7-H3, EGFR |